CH570368A5 - - Google Patents

Info

Publication number
CH570368A5
CH570368A5 CH1461170A CH1461170A CH570368A5 CH 570368 A5 CH570368 A5 CH 570368A5 CH 1461170 A CH1461170 A CH 1461170A CH 1461170 A CH1461170 A CH 1461170A CH 570368 A5 CH570368 A5 CH 570368A5
Authority
CH
Switzerland
Application number
CH1461170A
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH570368A5 publication Critical patent/CH570368A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
CH1461170A 1969-10-02 1970-10-02 CH570368A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86338869A 1969-10-02 1969-10-02

Publications (1)

Publication Number Publication Date
CH570368A5 true CH570368A5 (ja) 1975-12-15

Family

ID=25341022

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1461170A CH570368A5 (ja) 1969-10-02 1970-10-02

Country Status (9)

Country Link
US (1) US3660487A (ja)
JP (1) JPS4935257B1 (ja)
BE (1) BE757005A (ja)
CH (1) CH570368A5 (ja)
DE (1) DE2048555A1 (ja)
FR (1) FR2070107B1 (ja)
GB (1) GB1331469A (ja)
NL (1) NL7014293A (ja)
ZA (1) ZA706631B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005795A1 (en) * 1987-12-23 1989-06-29 Aktiebolaget Hässle Novel antiarrhythmic agents ii

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1355909A (en) * 1971-05-12 1974-06-12 Lepetit Spa Beta-blocking aminobutanols
JPS4867235A (ja) * 1971-12-17 1973-09-13
US3985897A (en) * 1973-12-21 1976-10-12 Mead Johnson & Company Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines
DE2528697C2 (de) * 1975-06-27 1986-02-20 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Salicylaldehyden
CA1120058A (en) * 1978-07-03 1982-03-16 Jack Mills Phenethanolamines, formulations and potentiation of oncolytic drugs
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4507320A (en) * 1983-12-07 1985-03-26 Smithkline Beckman Corporation Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
EP0164865B1 (en) * 1984-05-04 1988-12-21 The Upjohn Company N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
GB8619472D0 (en) * 1986-08-09 1986-09-17 Pfizer Ltd Anti-arrhythmia agents
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US5527830A (en) * 1993-09-13 1996-06-18 The Ohio State University Drugs for the treatment of cardiac arrest and other shock states
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
FR2724654B1 (fr) * 1994-09-16 1997-12-12 Roussel Uclaf Nouveaux derives de l'acide gallique, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005795A1 (en) * 1987-12-23 1989-06-29 Aktiebolaget Hässle Novel antiarrhythmic agents ii
WO1989005806A1 (en) * 1987-12-23 1989-06-29 Ab Hässle Novel antiarrhythmic agents iii
US5034411A (en) * 1987-12-23 1991-07-23 Aktiebolaget Hassle Novel 4-cyanophenyl derivatives with action against cardiac arrhythmia

Also Published As

Publication number Publication date
GB1331469A (en) 1973-09-26
JPS4935257B1 (ja) 1974-09-20
FR2070107A1 (ja) 1971-09-10
BE757005A (fr) 1971-04-02
NL7014293A (ja) 1971-04-06
DE2048555A1 (de) 1971-04-15
FR2070107B1 (ja) 1974-06-21
US3660487A (en) 1972-05-02
ZA706631B (en) 1971-05-27

Similar Documents

Publication Publication Date Title
AU465413B2 (ja)
AU450150B2 (ja)
AU2355770A (ja)
AU442375B2 (ja)
AU470301B1 (ja)
AU5113869A (ja)
AU470661B1 (ja)
AU442535B2 (ja)
AU442357B2 (ja)
AU442380B2 (ja)
AU442538B2 (ja)
AU410358B2 (ja)
AU442463B2 (ja)
AU414607B2 (ja)
AU417208B2 (ja)
AU442554B2 (ja)
AU4949169A (ja)
AU5077469A (ja)
AU5109569A (ja)
AU4982068A (ja)
CH273869A4 (ja)
BE737713A (ja)
AU5066368A (ja)
BE742344A (ja)
AU3648969A (ja)

Legal Events

Date Code Title Description
PL Patent ceased